Sun Pharma Q1FY24 net profit fell 2% YoY to Rs 2023 crore due to exceptional items worth Rs 323 crore. However, excluding exceptional items, net profit for Q1FY24 grew 13.8% to Rs 2345 crore. Earnings for interest, tax, depreciation, and ammortisation (EBITDA) grew 15.5% to Rs 3332 crore in Q1.